Cargando…
Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure
BACKGROUND: Metabolic impairment is an important contributor to heart failure (HF) pathogenesis and progression. Dysregulated metabolic pathways remain poorly characterized in patients with HF and preserved ejection fraction (HFpEF). We sought to determine metabolic abnormalities in HFpEF and identi...
Autores principales: | Hunter, Wynn G., Kelly, Jacob P., McGarrah, Robert W., Khouri, Michel G., Craig, Damian, Haynes, Carol, Ilkayeva, Olga, Stevens, Robert D., Bain, James R., Muehlbauer, Michael J., Newgard, Christopher B., Felker, G. Michael, Hernandez, Adrian F., Velazquez, Eric J., Kraus, William E., Shah, Svati H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015273/ https://www.ncbi.nlm.nih.gov/pubmed/27473038 http://dx.doi.org/10.1161/JAHA.115.003190 |
Ejemplares similares
-
Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy
por: Truby, Lauren K., et al.
Publicado: (2021) -
Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes
por: Lerman, Joseph B., et al.
Publicado: (2022) -
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021) -
Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction After a Recent Worsening Heart Failure Event
por: Carnicelli, Anthony P., et al.
Publicado: (2021) -
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: AbouEzzeddine, Omar F., et al.
Publicado: (2017)